Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
or

Nxstage Medical Inc (NXTM)

Nxstage Medical Inc (NXTM)
30.00 +0.01 (+0.03%) 02/21/19 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
Quote Overview for Thu, Feb 21st, 2019
Day Low
29.98
Day High
30.00
Open 30.00
Previous Close 29.99 29.99
Volume 2,608,300 2,608,300
Avg Vol 1,543,615 1,543,615
Stochastic %K 96.00% 96.00%
Weighted Alpha +21.20 +21.20
5-Day Change +0.83 (+2.85%) +0.83 (+2.85%)
52-Week Range 23.17 - 30.00 23.17 - 30.00
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,000,400
  • Shares Outstanding, K 66,685
  • Annual Sales, $ 393,940 K
  • Annual Income, $ -14,470 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 0.25
  • Price/Sales 4.70
  • Price/Cash Flow 103.07
  • Price/Book 8.71
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.08
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 02/22/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical Products

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate 0.03
  • Number of Estimates 2
  • High Estimate 0.04
  • Low Estimate 0.02
  • Prior Year -0.03
  • Growth Rate Est. (year over year) +200.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
28.00 +7.14%
on 01/25/19
Period Open: 28.50
30.00 unch
on 02/21/19
+1.50 (+5.26%)
since 01/18/19
3-Month
26.00 +15.38%
on 11/30/18
Period Open: 29.07
30.00 unch
on 02/21/19
+0.93 (+3.20%)
since 11/21/18
52-Week
23.17 +29.48%
on 03/01/18
Period Open: 24.38
30.00 unch
on 02/21/19
+5.62 (+23.05%)
since 02/21/18

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

NxStage Medical, Inc. is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative systems for the treatment of end-stage renal disease, or ESRD, and acute kidney failure.

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 30.01
1st Resistance Point 30.01
Last Price 30.00
1st Support Level 29.99
2nd Support Level 29.97
3rd Support Level N/A

See More

52-Week High 30.00
Last Price 30.00
Fibonacci 61.8% 27.39
Fibonacci 50% 26.58
Fibonacci 38.2% 25.78
52-Week Low 23.17

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trader's Cheat Sheet: Your Secret Weapon for Smarter Trades